Új vizsgálatok, publikációk, preprintek és pályázatok ezen a célponton, hónapról hónapra.
Vizsgálat
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
2026. nov. 11.· PHASE1 · RECRUITING· CTGOV
Publikáció
Retraction Note: Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
2026. nov. 5.· Journal of experimental & clinical cancer research : CR· PUBMED
Publikáció
Dihydrotanshinone I in Paired Vemurafenib-Sensitive and Resistant A375 Melanoma Cells.
2026. nov. 5.· Journal of visualized experiments : JoVE· PUBMED
Publikáció
Statement of Retraction: MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
2026. nov. 5.· Bioengineered· PUBMED
Publikáció
Impact of nano-chitosan solution on psoriasis-like thin skin lesion induced by imiquimod in Wistar rats: Exploring novel epigenetic role targeting miR-155, JAK2/STAT3/RORC/IL-17A, and MyD88/NF-κB pathways.
2026. nov. 4.· Histology and histopathology· PUBMED
Publikáció
NOP2/Sun domain 4-mediated m5C methylation of Janus kinase 1 promotes hepatocellular carcinoma progression.
2026. nov. 4.· Cell adhesion & migration· PUBMED
Publikáció
INHBA Inhibits ANXA9 Ubiquitination and Activates STAT3 to Drive Gastric Cancer Proliferation and Metastasis.
2026. nov. 4.· Archives of biochemistry and biophysics· PUBMED
Publikáció
Danvatirsen plus Pembrolizumab versus Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (PEMDA-HN): A Randomized, Phase II Trial.
2026. nov. 2.· Clinical cancer research : an official journal of the American Association for Cancer Research· PUBMED
Vizsgálat
A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid Tumors
2026. nov. 1.· PHASE1_PHASE2 · NOT_YET_RECRUITING· CTGOV
Publikáció
The Histone Lactylation of KREMEN2 Inhibits Ferroptosis Through the JAK2/STAT3/GPX4 Axis and Promotes the Progression of Mantle Cell Lymphoma.
2026. nov. 1.· Hematological oncology· PUBMED
Publikáció
Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis.
2026. nov. 1.· Clinical and translational medicine· PUBMED
Publikáció
Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-κB pathways.
2026. nov. 1.· Pakistan journal of pharmaceutical sciences· PUBMED
Publikáció
Serpin A1 Cargo Within Tumour-Derived Extracellular Vesicles Supports Pro-Tumoural Bias of Neutrophils in Cancer.
2026. nov. 1.· Journal of extracellular vesicles· PUBMED
Publikáció
Jolkinolide B induces apoptosis and G1 arrest in A549 cells via JAK2/STAT3 inhibition.
2026. nov. 1.· Pakistan journal of pharmaceutical sciences· PUBMED
Publikáció
MAGI3 Acts as an Intestinal Epithelial Gatekeeper in Inflammation-Associated Colorectal Cancer by Suppressing the STAT3-CCL2 Axis and TAM-Mediated Immunosuppression.
2026. okt. 31.· Advanced science (Weinheim, Baden-Wurttemberg, Germany)· PUBMED
Publikáció
Acquired TRAIL Resistance Promotes Cancer Stemness and Malignant Behavior through CD44-SPHK1-STAT3 Signaling in Colorectal Cancer.
2026. okt. 30.· Biomolecules & therapeutics· PUBMED
Publikáció
LMP2A Promotes Immune Escape by Regulating PD-L1 Expression via the PI3K/AKT/STAT3 Axis in EBV-Positive Gastric Cancer.
2026. okt. 30.· Experimental cell research· PUBMED
Publikáció
Recombinant RANKL protects against brain injury in intracerebral haemorrhage by regulating microglial phenotypes via the STAT3 pathway.
2026. okt. 29.· Brain injury· PUBMED
Publikáció
A pectic polysaccharide from Lonicera japonica alleviates DNCB-induced atopic dermatitis-like inflammation associated with gut microbial and metabolic alterations and reduced cutaneous JAK2/STAT3 activation and Th17 responses.
2026. okt. 29.· Journal of ethnopharmacology· PUBMED
Publikáció
CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway.
2026. okt. 28.· Oncology research· PUBMED
Publikáció
Collagen type I alpha 1 chain induces M2 macrophage polarization via integrin α2β1/JAK2/STAT3 pathway to promote gastric cancer progression.
2026. okt. 28.· Tissue & cell· PUBMED
Publikáció
RNA binding motif protein 15 (RBM15) inhibits macrophage phagocytosis via m6A-dependent colony stimulating factor 2 (CSF2)/STAT3 pathway in pancreatic cancer.
2026. okt. 28.· International journal of biological macromolecules· PUBMED
Publikáció
An MMP-14/STAT3 feedback loop upregulates PD-L1 to drive immunosuppression and tumorigenesis in bladder cancer.
2026. okt. 28.· iScience· PUBMED
Publikáció
Disruption of the N-terminal domain in a STAT3 hyper-IgE syndrome variant causes disease by sequestering STAT3 in the cytoplasm.
2026. okt. 27.· Science signaling· PUBMED
Publikáció
Low expression of SGPL1 promotes HCC progression by modulating LacCer metabolism via the S1P-STAT3-B4GALT6 axis.
2026. okt. 26.· Journal of lipid research· PUBMED
Publikáció
Retraction: Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition.
2026. okt. 26.· PloS one· PUBMED
Publikáció
Calsyntenin-2 promotes the pathology of acute myeloid leukemia via activation of the JAK2-STAT3 signaling pathway.
2026. okt. 25.· Cellular signalling· PUBMED
Publikáció
[Research progress on the multi-target modulation of signaling pathways by acupuncture in the treatment of obesity].
2026. okt. 25.· Zhen ci yan jiu = Acupuncture research· PUBMED
Publikáció
Repurposing the bitter taste receptor TAS2R14 as a pro-ferroptotic driver in thyroid cancer via the STAT3-HCG11-miR-450b-5p axis.
2026. okt. 25.· Acta biochimica et biophysica Sinica· PUBMED
Publikáció
Artesunate targets STAT3 to alleviate Hodgkin's lymphoma via JAK-STAT/PD-L1 axis.
2026. okt. 24.· Biochemical pharmacology· PUBMED